Effects of exogenous interleukin-7 on CD8(+) T-cell survival and function in human T-cell lymphotropic virus type 1 infection

Abstract Interleukin-7 (IL-7) mediates T-cell homeostasis through its effects on T-cell development, survival and function. In human T-cell lymphotropic virus type 1 (HTLV-1) infection, which is causally implicated in adult T-cell leukemia (ATL), the efficiency with which CD8(+) cytotoxic T-lymphocytes (CTLs) clear HTLV-1-infected cells mediates viral control and may be related to disease progression. We report here that CD127 expression in CD8(+) T-cells is independently related to disease status, and that exogenous IL-7 enhances CD8(+) T-cell survival and clearance of HTLV-1 infected cells in vitro. We conclude that CD127 down-regulation may be associated with disease status in HTLV-1 infection, and propose that exogenous IL-7 may be useful immunotherapy or cytokine adjuvant for an anti-ATL therapeutic vaccine.

[1]  R. Siliciano,et al.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. , 2012, Immunity.

[2]  Zheng Zhang,et al.  Progressive CD127 down‐regulation correlates with increased apoptosis of CD8 T cells during chronic HIV‐1 infection , 2009, European journal of immunology.

[3]  C. Tei,et al.  PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients , 2009, Leukemia.

[4]  A. Fauci,et al.  The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands , 2008, The Journal of Immunology.

[5]  D. Venzon,et al.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets , 2008, The Journal of experimental medicine.

[6]  J. Goedert,et al.  Risk of human T‐lymphotropic virus type I‐associated diseases in Jamaica with common HLA types , 2007, International journal of cancer.

[7]  C. Tei,et al.  Anti‐HTLV‐1 tax antibody and tax‐specific cytotoxic T lymphocyte are associated with a reduction in HTLV‐1 proviral load in asymptomatic carriers , 2007, Journal of medical virology.

[8]  M. Matsuoka,et al.  Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5′ Long Terminal Repeat during Oncogenesis , 2007, Journal of Virology.

[9]  Michael Proschan,et al.  Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals , 2007, Proceedings of the National Academy of Sciences.

[10]  J. Klarquist,et al.  Loss of IL‐7 receptor alpha‐chain (CD127) expression in acute HCV infection associated with viral persistence , 2006, Hepatology.

[11]  K. Uozumi,et al.  Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients1 , 2006, The Journal of Immunology.

[12]  P. Calabresi,et al.  Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells , 2006, Journal of Neuroimmunology.

[13]  H. Blum,et al.  Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection , 2006, Journal of Virology.

[14]  E. Murphy,et al.  Global epidemiology of HTLV-I infection and associated diseases , 2005, Oncogene.

[15]  J. Altman,et al.  Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals1 , 2005, The Journal of Immunology.

[16]  J. Weber,et al.  Human T Cell Lymphotropic Virus Type I (HTLV-I)-Specific CD4+ T Cells: Immunodominance Hierarchy and Preferential Infection with HTLV-I1 , 2004, The Journal of Immunology.

[17]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[18]  C. Bangham,et al.  The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. , 2003, The Journal of general virology.

[19]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[20]  W. Leonard,et al.  IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Yoshinaga,et al.  HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. , 2001, AIDS research and human retroviruses.

[22]  M. Matsuoka,et al.  Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. , 2001, Blood.

[23]  M. Tomonaga,et al.  A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 , 2001, British journal of haematology.

[24]  J. Weber,et al.  Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. , 2000, Blood.

[25]  C. Tei,et al.  Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma. , 1999, Leukemia & lymphoma.

[26]  B. Bain,et al.  Prospective study of HTLV-I infection in an initially asymptomatic cohort. , 1999, Journal of acquired immune deficiency syndromes.

[27]  C. Tei,et al.  NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications , 1999 .

[28]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[29]  S. Izumo,et al.  Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp , 1998 .

[30]  D. Spiegelman,et al.  Predictors of level of circulating abnormal lymphocytes among human T‐lymphotropic virus type I carriers in Japan , 1998, International journal of cancer.

[31]  M. Matsuoka,et al.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. , 1997, Cancer research.

[32]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[33]  K. Tajima.  The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features , 1990, International journal of cancer.

[34]  F. Saal,et al.  High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. , 1990, Blood.

[35]  M. Yoshida,et al.  Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I , 1989, Journal of virology.

[36]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.

[38]  I. Mahé,et al.  The Vote of Acute Medical Inpatients , 2009, Journal of aging and health.

[39]  Mihnea Moldoveanu,et al.  The common will , 1999 .

[40]  R. L. Burger,et al.  Isolation and Characterization , 2022 .